上皮剪接调节蛋白1(Epithelial splicing regulatory protein 1,ESRP1)是近年来发现的一种上皮细胞特异性剪接因子,主要通过选择性剪接在转录后水平调节基因的表达,继而影响细胞的功能。研究表明,ESRP1通过调控上皮间质转化、细胞周期...上皮剪接调节蛋白1(Epithelial splicing regulatory protein 1,ESRP1)是近年来发现的一种上皮细胞特异性剪接因子,主要通过选择性剪接在转录后水平调节基因的表达,继而影响细胞的功能。研究表明,ESRP1通过调控上皮间质转化、细胞周期进展、氧化还原反应以及脂肪酸代谢等过程,多方面参与肿瘤的发生、发展和对治疗药物的反应。小鼠实验研究表明,ESRP1基因敲除可以导致多种器官发育异常,包括颅面部畸形、皮肤屏障功能受损、肾脏以及耳蜗发育不良等。此外,ESRP1还可以通过调控转录因子的活性以及非编码RNA的生成,提高小鼠成纤维细胞重编程为多能干细胞的效率并维持人胚胎干细胞的多能性。鉴于ESRP1在多个研究领域的重要性,本文对ESRP1常见的下游靶分子、信号通路、以及在生理病理环境下所发挥的功能进行阐述,以期进一步指导基础研究和临床应用。展开更多
Objective:To investigate whether peroxisome proliferator-activated receptorγ(PPARγ)agonists,rosiglitazone and GW1929,activate the phosphatidylinositol 3-kinase(PI3K)-AKT/protein kinase B pathway and the mitogen-acti...Objective:To investigate whether peroxisome proliferator-activated receptorγ(PPARγ)agonists,rosiglitazone and GW1929,activate the phosphatidylinositol 3-kinase(PI3K)-AKT/protein kinase B pathway and the mitogen-activated protein kinase(MAPK)/extracellular signal-regulated kinase1/2(ERK1/2)pathway by upgrading the expression of chemerin.Methods:The HTR-8/SVneo trophoblastic cells were cultured in vitro in high glucose concentration(25 mmol/L)to mimic gestational diabetic phenotypes.We transfected small interfering RNA into HTR-8/SVneo cells to silence two receptors of chemerin,that are chemokine-like receptor 1(CMKLR1)and G protein-coupled receptor1(GPR1).And recombinant human chemerin,PPARγagonists(rosiglitazone,10μmol/L and GW1929,10μmol/L)and PPARγinhibitor(GW9662,5μmol/L)were additionally added to the medium,respectively.The existence of chemerin was verified by immunocytochemistry,and the expressions of PPARγ,chemerin,and its receptors as well as insulin signaling-related factors PI3K,AKT2,and MAPK(ERK1/2)were detected by real time quantitative-polymerase chain reaction and western blot.Results:Chemerin existed in the HTR-8/SVneo cells.Effects of chemerin on PI3K-AKT pathway and MAPK(ERK1/2)pathway were dependent on the density of chemerin.When rosiglitazone and GW1929 were added to the medium,the mRNA levels of PI3K,AKT2,and MAPK1 were upregulated(P<0.05).Conversely,GW9662 downregulated the mRNA levels of AKT2 and MAPK1(P<0.05).Rosiglitazone and GW1929 increased the protein levels of PPARγ,chemerin,CMKLR1 and GPR1(P<0.05).Rosiglitazone and GW1929 had no effect on the expression of PI3K p110βand phospho-AKT2 without CMKLR1(P>0.05).Meanwhile,the expression of phospho-ERK2 remained unaffected in the absence of GPR1(P>0.05).Conclusion:Both rosiglitazone and GW1929 have the effect of improving insulin signaling pathways via upgrading the level of chemerin in high glucose treated HTR-8/SVneo cells.展开更多
文摘上皮剪接调节蛋白1(Epithelial splicing regulatory protein 1,ESRP1)是近年来发现的一种上皮细胞特异性剪接因子,主要通过选择性剪接在转录后水平调节基因的表达,继而影响细胞的功能。研究表明,ESRP1通过调控上皮间质转化、细胞周期进展、氧化还原反应以及脂肪酸代谢等过程,多方面参与肿瘤的发生、发展和对治疗药物的反应。小鼠实验研究表明,ESRP1基因敲除可以导致多种器官发育异常,包括颅面部畸形、皮肤屏障功能受损、肾脏以及耳蜗发育不良等。此外,ESRP1还可以通过调控转录因子的活性以及非编码RNA的生成,提高小鼠成纤维细胞重编程为多能干细胞的效率并维持人胚胎干细胞的多能性。鉴于ESRP1在多个研究领域的重要性,本文对ESRP1常见的下游靶分子、信号通路、以及在生理病理环境下所发挥的功能进行阐述,以期进一步指导基础研究和临床应用。
基金This study was supported by the National Key R&D Program of China(No.2016YFC1000405 and No.2018YFC1002903)
文摘Objective:To investigate whether peroxisome proliferator-activated receptorγ(PPARγ)agonists,rosiglitazone and GW1929,activate the phosphatidylinositol 3-kinase(PI3K)-AKT/protein kinase B pathway and the mitogen-activated protein kinase(MAPK)/extracellular signal-regulated kinase1/2(ERK1/2)pathway by upgrading the expression of chemerin.Methods:The HTR-8/SVneo trophoblastic cells were cultured in vitro in high glucose concentration(25 mmol/L)to mimic gestational diabetic phenotypes.We transfected small interfering RNA into HTR-8/SVneo cells to silence two receptors of chemerin,that are chemokine-like receptor 1(CMKLR1)and G protein-coupled receptor1(GPR1).And recombinant human chemerin,PPARγagonists(rosiglitazone,10μmol/L and GW1929,10μmol/L)and PPARγinhibitor(GW9662,5μmol/L)were additionally added to the medium,respectively.The existence of chemerin was verified by immunocytochemistry,and the expressions of PPARγ,chemerin,and its receptors as well as insulin signaling-related factors PI3K,AKT2,and MAPK(ERK1/2)were detected by real time quantitative-polymerase chain reaction and western blot.Results:Chemerin existed in the HTR-8/SVneo cells.Effects of chemerin on PI3K-AKT pathway and MAPK(ERK1/2)pathway were dependent on the density of chemerin.When rosiglitazone and GW1929 were added to the medium,the mRNA levels of PI3K,AKT2,and MAPK1 were upregulated(P<0.05).Conversely,GW9662 downregulated the mRNA levels of AKT2 and MAPK1(P<0.05).Rosiglitazone and GW1929 increased the protein levels of PPARγ,chemerin,CMKLR1 and GPR1(P<0.05).Rosiglitazone and GW1929 had no effect on the expression of PI3K p110βand phospho-AKT2 without CMKLR1(P>0.05).Meanwhile,the expression of phospho-ERK2 remained unaffected in the absence of GPR1(P>0.05).Conclusion:Both rosiglitazone and GW1929 have the effect of improving insulin signaling pathways via upgrading the level of chemerin in high glucose treated HTR-8/SVneo cells.
